logo-loader
viewFresenius Medical Care

Fresenius Medical Care acquires renal information software NephroCare

medical_chart350_4b504b099a497.jpg

Fresenius Medical Care (NYSE: FMS) has completed the purchase of sole Canadian development and distribution rights to the NephroCare software from Cybernius Medical.


NephroCare is a comprehensive renal information system that electronically manages and reports patient data.
“The NephroCare(R) software allows easy access at the patient's bedside to enable point of care charting in the electronic patient record. It can also provide remote access to patient data for care givers and allow patients access to their own information through patient portal links,” Fresenius Medical Care stated.


Fresenius Medical Care has been distributing NephroCare in Canada for ten years.


Juan Sanchez, FMCC President stated: "Owning the NephroCare software clearly supports our vision to be first choice in renal therapies and reflects well on our on-going commitment to the Canadian renal eHealth market."


Fresenius Medical Care is an integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure.

Quick facts: Fresenius Medical Care

Price: 36.51 USD

NYSE:FMS
Market: NYSE
Market Cap: $21.93 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Preveceutical announces successful preliminary evaluation of...

Preveceutical (CSE:PREV-OTCQB: PRVCF) President Mak Jawadeker joined Steve Darling from Proactive Vancouver on Skype to discuss the company successfully completing the design, synthesis and preliminary evaluation of key peptides from its scorpion venom-derived peptide research and development...

1 day, 6 hours ago

2 min read